Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID­19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment.

Yurttutan, Sadik; Gullu, Utku Ufuk; Ipek, Sevcan

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment.

Yurttutan, Sadik; Gullu, Utku Ufuk; Ipek, Sevcan.

Afiliação

Yurttutan S; Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Avsar Campus, 46100, Kahramanmaras, Turkey. dryurttutan@gmail.com.
Gullu UU; Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
Ipek S; Division of Pediatric Intensive Care Unit, Department of Pediatrics, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.

Intern Emerg Med ; 16(4): 1101-1103, 2021 06.

Article em En | MEDLINE | ID: mdl-33598871

Assuntos

Tratamento Farmacológico da COVID-19; Proteína Antagonista do Receptor de Interleucina 1; Corticosteroides/uso terapêutico; Anticorpos Monoclonais Humanizados; Humanos; Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico; Estudos Retrospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Antagonista do Receptor de Interleucina 1 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google